Assessment of liver function for safe hepatic resection
暂无分享,去创建一个
[1] O. Garden,et al. An 8‐year experience of hepatic resection: indications and outcome , 1998, The British journal of surgery.
[2] T. Pawlik,et al. Chemotherapy‐associated hepatotoxicity and surgery for colorectal liver metastases , 2007, The British journal of surgery.
[3] Yutaka Matsuyama,et al. Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.
[4] A. Sugioka,et al. Hepatic resection for hepatocellular carcinoma. , 1990, Surgery.
[5] M. Makuuchi,et al. One thousand fifty-six hepatectomies without mortality in 8 years. , 2003, Archives of surgery.
[6] G. Gerken,et al. Quantitative liver function tests in donors and recipients of living donor liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] Norio Nakao,et al. A novel 3D hepatectomy simulation based on liver circulation: Application to liver resection and transplantation , 2005, Hepatology.
[8] K Torizuka,et al. [Phase I clinical study on 99mTc-GSA, a new agent for functional imaging of the liver]. , 1991, Kaku igaku. The Japanese journal of nuclear medicine.
[9] S. Kawasaki,et al. Preoperative portal vein embolization: An audit of 84 patients , 1999, Hepatology.
[10] S. Cha,et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality , 2005, Journal of Gastrointestinal Surgery.
[11] H. Petrowsky,et al. Strategies for safer liver surgery and partial liver transplantation. , 2007, The New England journal of medicine.
[12] M. Makuuchi,et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. , 1990, Surgery.
[13] S. Saleh,et al. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients. , 2007, European journal of pharmacology.
[14] C. Scudamore,et al. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. , 1992, American journal of surgery.
[15] E. Abdalla,et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome , 2007, The British journal of surgery.
[16] J. Bruix,et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. , 1996, Gastroenterology.
[17] T. Eberlein. Hepatic Insufficiency and Mortality in 1,059 Noncirrhotic Patients Undergoing Major Hepatectomy , 2008 .
[18] M. Makuuchi,et al. The role of preoperative phenylalanine breath test in hepatectomy. , 2003, Hepato-gastroenterology.
[19] Y Bandai,et al. Asialoglycoprotein receptor and hepatic blood flow using technetium-99m-DTPA-galactosyl human serum albumin. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] M. Makuuchi,et al. Measurement of liver volume and hepatic functional reserve as a guide to decision‐making in resectional surgery for hepatic tumors , 1997, Hepatology.
[21] C. G. Child,et al. Surgery and portal hypertension. , 1964, Major problems in clinical surgery.
[22] T. Muto,et al. Predictors of successful hepatic resection: Prognostic usefulness of hepatic asialoglycoprotein receptor analysis , 2002, World Journal of Surgery.
[23] M. Fried,et al. 13C‐methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry , 2007, Alimentary pharmacology & therapeutics.
[24] T. Utsunomiya,et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. , 1999, Journal of the American College of Surgeons.
[25] S. Curley,et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. , 2007, Journal of the American College of Surgeons.
[26] T M Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.
[27] M. Vivarelli,et al. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. , 2006, Journal of the American College of Surgeons.
[28] M. Makuuchi,et al. Three-dimensional computed tomography for planning donor hepatectomy. , 2007, Transplantation proceedings.
[29] K Torizuka,et al. [Phase II clinical study on 99mTc-GSA, a new agent for functional imaging of the liver]. , 1991, Kaku igaku. The Japanese journal of nuclear medicine.
[30] T. Sato,et al. Recovery of hepatic asialoglycoprotein receptors after major hepatic resection. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] O. Farges,et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. , 2000, Journal of the American College of Surgeons.
[32] R. Pugh,et al. Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.
[33] R. Wiesner,et al. Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.
[34] T. Nagayasu,et al. Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: Clinical evaluation and patient outcome. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.
[35] S. Kawasaki,et al. Surgery for small liver cancers. , 1993, Seminars in surgical oncology.
[36] F. Chang,et al. Proposal of a modified Child‐Turcotte‐Pugh scoring system and comparison with the model for end‐stage liver disease for outcome prediction in patients with cirrhosis , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[37] M. Makuuchi,et al. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. , 2005, Journal of hepato-biliary-pancreatic surgery.
[38] S. Fan,et al. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. , 1995, Archives of surgery.
[39] P O Scheibe,et al. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[40] N. Yamanaka,et al. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. , 1994, Cancer treatment and research.
[41] S K Ha-Kawa,et al. A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[42] W. Hawkins,et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. , 2005, Journal of the American College of Surgeons.
[43] J. Bruix,et al. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.
[44] M. Makuuchi,et al. Report of the 16th follow-up survey of primary liver cancer. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.
[45] M. Büchler,et al. Preoperative Galactose Elimination Capacity Predicts Complications and Survival After Hepatic Resection , 2002, Annals of surgery.
[46] M. Makuuchi,et al. Long-Term Outcome of Extended Hemihepatectomy for Hilar Bile Duct Cancer With No Mortality and High Survival Rate , 2003, Annals of surgery.
[47] P. Kamath,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.
[48] S. Orloff,et al. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis. , 2008, American journal of surgery.
[49] K. Man,et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy , 1997, The British journal of surgery.
[50] R. Schulick. Assessment of Liver Function in the Surgical Patient , 2007 .
[51] D. Vera,et al. Evaluation of hepatocellular function by way of receptor‐mediated uptake of a technetium‐99m—labeled asialoglycoprotein analog , 1994, Hepatology.
[52] J. Meakins,et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. , 1990, Gastroenterology.
[53] D. Nagorney,et al. Predictive indices of morbidity and mortality after liver resection. , 2006, Annals of surgery.
[54] M. Makuuchi,et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. , 2004, Archives of surgery.
[55] K. Do,et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. , 2000, Surgery.
[56] T. Pawlik,et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[57] M. Makuuchi,et al. Clinical application of TcGSA. , 2003, Nuclear medicine and biology.
[58] S. Kawasaki,et al. Criteria for safe hepatic resection. , 1995, American journal of surgery.
[59] Y. Matsui,et al. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. , 2006, Surgery.